Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes

Article Abstract:

The selective inhibition of cyclic nucleotide phosphodiesterase isoenzymes (PDI) affects the cyclic nucleotide levels and promotes the modulation of tissue functions at different subcellular sites. This property makes PDI selective inhibitors such as 1-methyl-2-isobutyl-8-methoxyethyl xanthine and denbufylline useful in the determination of the effects of isoenzymes on cyclic nucleotide hydrolysis. Furthermore, these PDI selective inhibitors can be therapeutically employed in various illnesses such as congestive heart failure, asthma, central disorders and hypertension.

Author: Nicholson, C. David, Challiss, R.A. John, Shahid, Mohammed
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1991
Isoenzymes, Phosphodiesterases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


An approach to the development of novel antihypertensive drugs: Potential role of sodium pump inhibitors

Article Abstract:

The search for the endogenous sodium pump inhibitor (SPI) is crucial to the understanding of hypertension and to the development of antihypertensive drugs. Researchers have identified the oubain-like compound, digoxin-like compound, cardenolide-lipid conjugates and bufodienolide SPIs as possible regulators of blood pressure in humans and mammals. These compounds are believed to regulate sodium reabsorption by the kidney which leads to hypertension. Animal studies support the theory that SPI contributes to the development of hypertension.

Author: Goto, Atsuo, Yamada, Kaoru
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1998
Hypertension, Drug therapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Handy and Moore reply

Article Abstract:

The enzyme inhibitor 7-nitroindazole does not affect the endothelium-dependent relaxation of the blood vessels or increase in systemic blood pressure in anaesthetized rats contrary to claims. It was not mentioned that the observed vascular effects were concentrated only in the peripheral and central nervous systems and does not affect systemic blood pressure. The vascular effect of 7-NI is limited to the central nervous system and is attributed to the inhibition of neuronal nitric oxide formation.

Author: Handy, Rachel L.C., Moore, Philip K.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1998
Research, Blood vessels, Physiological regulation, Biological control systems

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Physiological aspects, Enzyme inhibitors, Blood pressure, Blood pressure regulation
Similar abstracts:
  • Abstracts: Conformational induction versus conformational selection: evidence from allosteric enhancers. Pharmacological proteus?
  • Abstracts: Therapeutic potential of cytokine manipulation. Lipocortin-1 exhibits novel actions, providing clinical opportunities
  • Abstracts: The dioxin and peroxisome proliferator-activated receptors: nuclear receptors in search of endogenous ligands
  • Abstracts: 5-HT4 receptor agonists and bladder disorders. Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning
  • Abstracts: Latest eruptions in metabotropic glutamate receptors. The structure and signalling properties of 5-HT receptors: an endless diversity?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.